JP2011507826A5 - - Google Patents

Download PDF

Info

Publication number
JP2011507826A5
JP2011507826A5 JP2010538924A JP2010538924A JP2011507826A5 JP 2011507826 A5 JP2011507826 A5 JP 2011507826A5 JP 2010538924 A JP2010538924 A JP 2010538924A JP 2010538924 A JP2010538924 A JP 2010538924A JP 2011507826 A5 JP2011507826 A5 JP 2011507826A5
Authority
JP
Japan
Prior art keywords
pharmaceutical formulation
mixture
pharmaceutical
tolperisone
gel
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2010538924A
Other languages
English (en)
Japanese (ja)
Other versions
JP2011507826A (ja
Filing date
Publication date
Priority claimed from HU0700828A external-priority patent/HUP0700828A2/hu
Application filed filed Critical
Publication of JP2011507826A publication Critical patent/JP2011507826A/ja
Publication of JP2011507826A5 publication Critical patent/JP2011507826A5/ja
Pending legal-status Critical Current

Links

JP2010538924A 2007-12-20 2008-12-18 トルペリゾンを含む医薬製剤 Pending JP2011507826A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
HU0700828A HUP0700828A2 (en) 2007-12-20 2007-12-20 Transdermal pharmaceutical compositions containing tolperisone alone and in combination
PCT/HU2008/000153 WO2009081217A1 (en) 2007-12-20 2008-12-18 Pharmaceutical formulations containing tolperisone

Publications (2)

Publication Number Publication Date
JP2011507826A JP2011507826A (ja) 2011-03-10
JP2011507826A5 true JP2011507826A5 (enExample) 2011-07-14

Family

ID=89987953

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2010538924A Pending JP2011507826A (ja) 2007-12-20 2008-12-18 トルペリゾンを含む医薬製剤

Country Status (7)

Country Link
US (1) US20100273746A1 (enExample)
EP (1) EP2231116A1 (enExample)
JP (1) JP2011507826A (enExample)
CA (1) CA2709538A1 (enExample)
EA (1) EA018536B1 (enExample)
HU (1) HUP0700828A2 (enExample)
WO (1) WO2009081217A1 (enExample)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2519193C2 (ru) * 2008-09-12 2014-06-10 Критикал Фармасьютикалс Лимитед Усовершенствование всасывания терапевтических средств через слизистые оболочки или кожу
JP5739679B2 (ja) * 2010-03-01 2015-06-24 ロート製薬株式会社 外用組成物
EA026697B1 (ru) 2011-05-03 2017-05-31 Апониа Лабораториз, Инк. Трансдермальные композиции ибупрофена и способы их применения
WO2012172413A1 (en) 2011-06-16 2012-12-20 Abbott Healthcare Pvt. Ltd. Pharmaceutical composition comprising a combination of eperisone and diclofenac and process for preparing thereof
KR101156054B1 (ko) * 2011-09-05 2012-06-20 주식회사 네비팜 안정한 에페리손 함유 서방성 의약조성물
UA119324C2 (uk) * 2013-04-02 2019-06-10 Теміс Медікер Лімітед Композиції фармацевтично активних речовин, що містять моноетиловий ефір діетиленгліколю або інші алкільні похідні
BR112017016010B1 (pt) * 2015-01-30 2023-02-14 Medrx Co., Ltd Preparação aquosa para uso externo.
RU2711624C2 (ru) * 2017-06-30 2020-01-17 Общество с ограниченной ответственностью "ФБК" Комбинированное средство на основе нпвс, миорелаксанта и витамина
TR201720293A2 (tr) * 2017-12-13 2019-06-21 Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi Tolperi̇zon ve non-selekti̇f cox i̇nhi̇bi̇törü kombi̇nasyonlari
WO2020086046A2 (en) * 2018-10-26 2020-04-30 Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi Topical compositions comprising tolperisone and flurbiprofen combination
AU2020379828A1 (en) 2019-11-06 2022-04-28 Smartech Topical, Inc. Topical formulations of cyclooxygenase inhibitors and their use
CN114939104B (zh) * 2022-06-02 2023-10-24 杭州润宠归美生物科技有限公司 一种用于减轻猫应激的外用透皮制剂、制备方法及应用

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6087215A (ja) * 1983-10-19 1985-05-16 Mitsui Toatsu Chem Inc 外用薬用基材
JPH0720866B2 (ja) * 1987-05-15 1995-03-08 三生製薬株式会社 エペリゾン又はトルペリゾン或いはそれらの塩類含有経皮適用製剤
US5719197A (en) * 1988-03-04 1998-02-17 Noven Pharmaceuticals, Inc. Compositions and methods for topical administration of pharmaceutically active agents
US5446070A (en) * 1991-02-27 1995-08-29 Nover Pharmaceuticals, Inc. Compositions and methods for topical administration of pharmaceutically active agents
US5093133A (en) * 1990-01-24 1992-03-03 Mcneil-Ppc, Inc. Method for percutaneous delivery of ibuprofen using hydroalcoholic gel
US5252588A (en) * 1990-04-27 1993-10-12 Sekisui Kagaku Kogyo Kabushiki Kaisha Percutaneously absorbable crosslinked polyvinylpyrrolidone eperisone or tolperisone preparation
JPH0640917A (ja) * 1991-06-21 1994-02-15 Nichiban Co Ltd トルペリゾン又はエペリゾン含有ハップ剤
JP3525225B2 (ja) * 1992-11-09 2004-05-10 積水化学工業株式会社 エペリゾンまたはトルペリゾン経皮吸収テープ剤またはパッチ剤、およびその製造方法
IT1265001B1 (it) * 1993-12-16 1996-10-17 Zambon Spa Composizione farmaceutica per uso topico contenente acido (s)-2-(4- isobutilfenil) propionico
US5733900A (en) * 1994-04-21 1998-03-31 Hisamitsu Pharmaceutical Co., Inc. Percutaneous administration base composition and percutaneous administration medicinal composition comprising said base composition and medicine
US5846620A (en) * 1997-02-06 1998-12-08 W. R. Grace & Co.-Conn. High strength flexible film package
JP2000143510A (ja) * 1998-11-16 2000-05-23 Taisho Pharmaceut Co Ltd 外用組成物
US20020004065A1 (en) * 2000-01-20 2002-01-10 David Kanios Compositions and methods to effect the release profile in the transdermal administration of active agents
US20050163831A1 (en) * 2002-08-02 2005-07-28 Hisamitsu Pharmaceutical Co., Inc. Patch for transdermal administration
KR101105612B1 (ko) * 2003-03-18 2012-01-18 히사미쓰 세이야꾸 가부시키가이샤 비스테로이드계 소염 진통제 함유 첩부제
US20070065463A1 (en) * 2003-06-20 2007-03-22 Ronald Aung-Din Topical therapy for the treatment of migranes, muscle sprains, muscle spasms, spasticity and related conditions
HUP0303313A2 (hu) * 2003-10-09 2005-07-28 Richter Gedeon Vegyészeti Gyár Rt. Transzdermális gyógyszerkészítmények
AT500144A1 (de) * 2004-03-05 2005-11-15 Sanochemia Pharmazeutika Ag Tolperison enthaltende, pharmazeutische zubereitung mit steuerbarer wirkstofffreisetzung zur oralen verabreichung
EP1737434A2 (en) * 2004-04-13 2007-01-03 Alza Corporation Apparatus and method for transdermal delivery of fentanyl-based agents
JP5324091B2 (ja) * 2004-06-24 2013-10-23 アイデックス ラボラトリーズ,インコーポレイティド 薬物送達のための医薬組成物及びそれを使用する症状の治療又は予防法
US20060004050A1 (en) * 2004-07-02 2006-01-05 Speicher Brian T Compositions and methods for the prevention or treatment of pain and other nervous system disorders
JP4782800B2 (ja) * 2004-12-17 2011-09-28 エクソンモービル・ケミカル・パテンツ・インク 均一ポリマー・ブレンドおよび該ブレンドからの製品
AT505225A1 (de) * 2007-04-26 2008-11-15 Sanochemia Pharmazeutika Ag 0erfahren zur herstellung von hoch reinem 2,4'-dimethyl-3-piperidino-propiophenon (tolperison), dieses enthaltende pharmazeutische zusammensetzungen, sowie tolperison enthaltende wirkstoffformulierungen

Similar Documents

Publication Publication Date Title
JP2011507826A5 (enExample)
US10039832B2 (en) Material and method for treating internal cavities
Almeida et al. Pluronic® F-127 and Pluronic Lecithin Organogel (PLO): Main features and their applications in topical and transdermal administration of drugs
ES2718688T3 (es) Forma de dosificación resistente a la manipulación para opioides sensibles a la oxidación
JP2021138773A (ja) 送達系、アミド型局所麻酔薬、およびメロキシカムを含む医薬組成物
KR100610403B1 (ko) 경구용 액상 또는 반-고체 조성물을 포함하는 약제학적 조성물 및 이의 제조방법
ES2663777T3 (es) Dispositivos de administración mucosa multidireccionales y métodos de uso
WO2012126278A1 (zh) 特比萘芬逆向温敏可逆水凝胶组合物
CN101790370A (zh) 一种新的双氯芬酸非水局部用溶液及其制备方法
JPS6261917A (ja) アリ−ルプロピオン酸誘導体の経皮的に吸収しうる含水製剤とその製造方法
JP2011507826A (ja) トルペリゾンを含む医薬製剤
US9289495B2 (en) Systems and methods for treatment of allergies and other indications
JP2010195823A (ja) 小動物用の注射可能な獣医用組成物
TW201124177A (en) Aqueous patch containing dichlofenac sodium
Mir et al. Pharmaceutical applications of lidocaine-based ionic liquids–a remarkable innovation in drug delivery
EP3452031A1 (en) Precision controlled load and release particles for post-operative pain
CN101415442B (zh) 控释凝胶
ES2829285T3 (es) Administración de AINE y composiciones, métodos y sistemas relacionados
TWI569815B (zh) Percutaneous absorption type preparation
ES2436503T3 (es) Composiciones farmacéuticas tópicas de gel de flurbiprofeno, glucosamina y condroitina
EP2793854B1 (en) Formulations of flurbiprofen and diacerein
MY150820A (en) Drug delivery system for administration of a water soluble, cationic and amphiphilic pharmaceutically active substance
EP2809305B1 (en) Bilayer tablet formulations of flurbiprofen and glucosamin
ES2913642T3 (es) Excipientes modificadores de la liberación a base de almidón y composiciones farmacéuticas derivadas de los mismos
Balavigneswaran et al. Polymeric gels for the controlled drug delivery applications